Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $35,738 | 4 | 55.9% |
| Food and Beverage | $15,506 | 284 | 24.3% |
| Travel and Lodging | $10,809 | 49 | 16.9% |
| Entertainment | $1,488 | 1 | 2.3% |
| Education | $358.33 | 3 | 0.6% |
| Gift | $15.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Southern Spine, LLC | $27,488 | 2 | $0 (2022) |
| Boston Scientific Corporation | $7,371 | 81 | $0 (2024) |
| Omnia Medical, LLC | $5,500 | 1 | $0 (2021) |
| Abbott Laboratories | $4,860 | 66 | $0 (2024) |
| Medtronic USA, Inc. | $3,767 | 42 | $0 (2020) |
| Interventional Pain Technologies Inc. | $2,750 | 1 | $0 (2021) |
| Nevro Corp. | $2,073 | 43 | $0 (2024) |
| Vertiflex, Inc. | $1,907 | 11 | $0 (2019) |
| Flowonix Medical Incorporated | $1,613 | 2 | $0 (2020) |
| Vertos Medical, Inc. | $879.41 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,494 | 41 | Nevro Corp. ($481.65) |
| 2023 | $924.06 | 33 | Abbott Laboratories ($498.36) |
| 2022 | $26,722 | 28 | Southern Spine, LLC ($24,288) |
| 2021 | $13,367 | 32 | Omnia Medical, LLC ($5,500) |
| 2020 | $6,704 | 70 | Boston Scientific Corporation ($4,272) |
| 2019 | $5,539 | 43 | Vertiflex, Inc. ($1,861) |
| 2018 | $4,461 | 51 | Medtronic USA, Inc. ($1,401) |
| 2017 | $4,702 | 44 | Abbott Laboratories ($2,003) |
All Payment Transactions
342 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Neuromodulation | ||||||
| 12/26/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Neuromodulation | ||||||
| 12/13/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Spinal Cord Stimulator | ||||||
| 12/10/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $5.93 | General |
| Category: Spinal Cord Stimulator | ||||||
| 12/06/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $62.03 | General |
| Category: General - Pain Management_NMD | ||||||
| 11/12/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $32.93 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/02/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $152.00 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/02/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $45.22 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/29/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $17.63 | General |
| 10/23/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $3.70 | General |
| Category: Neuromodulation | ||||||
| 10/17/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $11.08 | General |
| Category: Neuromodulation | ||||||
| 10/17/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $3.66 | General |
| Category: Neuromodulation | ||||||
| 10/01/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $42.72 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 09/07/2024 | Boston Scientific Corporation | NA (Device) | Food and Beverage | In-kind items and services | $80.19 | General |
| Category: G4 RF Generator_NM | ||||||
| 09/07/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 08/29/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $84.78 | General |
| 08/23/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $36.75 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 08/22/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $111.03 | General |
| Category: General - Pain Management_NMD | ||||||
| 08/14/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $117.27 | General |
| Category: Orthopedic | ||||||
| 08/01/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $8.12 | General |
| Category: Neuromodulation | ||||||
| 08/01/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $2.61 | General |
| Category: Neuromodulation | ||||||
| 07/30/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Neuromodulation | ||||||
| 07/17/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $19.38 | General |
| Category: NEUROLOGY | ||||||
| 06/25/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $2.16 | General |
| Category: Neuromodulation | ||||||
| 05/22/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: PAIN MANAGEMENT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 2,407 | 4,320 | $3.1M | $389,660 |
| 2022 | 30 | 2,060 | 3,250 | $1.5M | $295,120 |
| 2021 | 23 | 1,726 | 3,161 | $1.8M | $303,539 |
| 2020 | 21 | 1,831 | 3,862 | $1.7M | $279,624 |
All Medicare Procedures & Services
110 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 562 | 1,224 | $511,504 | $98,310 | 19.2% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 575 | 1,375 | $240,545 | $83,634 | 34.8% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 295 | 421 | $312,715 | $81,384 | 26.0% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 101 | 112 | $157,780 | $22,674 | 14.4% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 79 | 94 | $54,332 | $14,425 | 26.6% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Facility | 2023 | 21 | 64 | $444,334 | $14,324 | 3.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 52 | 88 | $98,385 | $8,542 | 8.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 71 | 71 | $38,158 | $7,284 | 19.1% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 101 | 112 | $176,200 | $7,188 | 4.1% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 26 | 46 | $736,000 | $7,034 | 1.0% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 27 | 29 | $39,208 | $6,002 | 15.3% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 52 | 88 | $51,456 | $4,907 | 9.5% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2023 | 21 | 40 | $25,571 | $4,462 | 17.5% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 37 | 51 | $44,310 | $3,285 | 7.4% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Facility | 2023 | 21 | 40 | $13,033 | $2,539 | 19.5% |
| 62369 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump | Office | 2023 | 25 | 43 | $13,029 | $2,418 | 18.6% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 34 | 36 | $11,295 | $2,394 | 21.2% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 28 | 30 | $39,000 | $2,117 | 5.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 37 | $10,878 | $2,097 | 19.3% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 23 | 25 | $19,650 | $2,052 | 10.4% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 27 | 47 | $8,695 | $1,746 | 20.1% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 17 | 18 | $8,262 | $1,716 | 20.8% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 12 | 14 | $5,614 | $1,570 | 28.0% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 14 | 20 | $10,520 | $1,499 | 14.2% |
| 63685 | Insertion of spinal neurostimulator generator or receiver | Facility | 2023 | 11 | 11 | $12,672 | $1,404 | 11.1% |
About Dr. Sameer Jain, M.D
Dr. Sameer Jain, M.D is a Neurology healthcare provider based in Bryant, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2013. The National Provider Identifier (NPI) number assigned to this provider is 1932548344.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sameer Jain, M.D has received a total of $63,914 in payments from pharmaceutical and medical device companies, with $1,494 received in 2024. These payments were reported across 342 transactions from 47 companies. The most common payment nature is "Consulting Fee" ($35,738).
As a Medicare-enrolled provider, Jain has provided services to 8,024 Medicare beneficiaries, totaling 14,593 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 110 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Interventional Pain Medicine
- Location Bryant, AR
- Active Since 06/19/2013
- Last Updated 03/17/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1932548344
Products in Payments
- SPECTRA WAVEWRITER (Device) $3,550
- Superion ISS (Device) $1,907
- SCS leads (Device) $1,860
- Prometra II (Device) $1,613
- Proclaim Family of SCS IPGs (Device) $1,442
- SYNCHROMED (Device) $1,162
- GENERAL - PAIN MANAGEMENT (Device) $904.85
- mild Device Kit (Device) $879.41
- OSTEOCOOL RF ABLATION (Device) $863.64
- Senza (Device) $856.50
- Intracept (Device) $826.50
- Sacroiliac Joint Fusion System (Device) $767.78
- KYPHON Balloon Kyphoplasty (Device) $732.66
- SUPERION (Device) $653.91
- RESTORE (Device) $608.06
- PROCLAIM (Device) $606.88
- Omnia (Device) $597.79
- Senza Spinal Cord Stimulation System (Device) $587.02
- 3D GraftRasp System (Device) $500.01
- INTELLIS (Device) $370.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.